Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management

Current Opinion in Allergy and Clinical Immunology
Mark S Dykewicz

Abstract

Angiotensin-converting enzyme inhibitors are widely prescribed for hypertension and heart failure. These drugs are commonly associated with cough, and are less commonly associated with angioedema, which may be potentially life threatening. This review describes data that extend our understanding of the mechanisms of these reactions, and provides guidance about clinical management. For patients who develop angioedema from angiotensin-converting enzyme inhibitors, recent data are reassuring that the majority of such patients can tolerate angiotensin-II receptor blockers. These data support earlier conclusions that most patients with angiotensin-converting enzyme inhibitor-induced cough can tolerate angiotensin-II receptor blockers. Limited case reports suggest that in acute angioedema induced by angiotensin-converting enzyme inhibitors, patients refractory to standard treatment may benefit from the infusion of fresh frozen plasma. Although data are incomplete, it appears that angiotensin-converting enzyme inhibitors cause cough and angioedema through a cascade of effects that begins with the accumulation of kinins, and then involves arachidonic acid metabolism and nitric oxide generation. Most patients who develop either cough or...Continue Reading

References

Feb 1, 1991·The American Journal of Medicine·A Agostoni, M Cicardi
Sep 12, 1990·JAMA : the Journal of the American Medical Association·N OrfanM S Dykewicz
Jun 1, 1995·Journal of Clinical Epidemiology·L E VisserA Bakker
Jan 1, 1996·Annual Review of Pharmacology and Toxicology·K K GriendlingR W Alexander
Apr 2, 1998·Respiration; International Review of Thoracic Diseases·P V Dicpinigaitis, K Rauf
Apr 8, 1998·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·W VleemingD J de Wildt
Jul 23, 1999·Pharmacotherapy·C A Luque, M Vazquez Ortiz
Jul 11, 2000·Archives of Internal Medicine·E GrossmanJ M Neutel
Feb 24, 2001·European Journal of Clinical Pharmacology·C MeuneC Caulin
Feb 14, 2002·The Journal of Allergy and Clinical Immunology·Mohammed Yousuf Karim, Amina Masood
Mar 13, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Laurence G Howes, Diane Tran
Aug 23, 2002·The New England Journal of Medicine·Juerg NussbergerMarco Cicardi
Sep 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Giuseppe MolinaroAlbert Adam
Jun 12, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Manoj R WarrierRaymond G Slavin

❮ Previous
Next ❯

Citations

Feb 26, 2010·Diabetology & Metabolic Syndrome·Renata C AlencarMarília B Gomes
Aug 24, 2010·Vascular Health and Risk Management·Domenico GalzeranoCarlo Gaudio
Aug 22, 2015·The Journal of Cardiovascular Nursing·Sara Paul, Robert L Page
Feb 24, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Marian C NeidertOliver Bozinov
Apr 11, 2013·Clinics in Geriatric Medicine·Ammar M AhmedJason Reichenberg
Oct 12, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·UNKNOWN Joint Task Force on Practice ParametersUNKNOWN Joint Council of Allergy, Asthma and Immunology
Jul 14, 2006·Mayo Clinic Proceedings·Catherine R Weiler, Richard G van Dellen
Jul 25, 2014·The American Journal of Medicine·Shira BezalelZev Moshe Sthoeger
Aug 16, 2016·British Journal of Clinical Pharmacology·Seyed Hamidreza MahmoudpourUNKNOWN PREDICTION-ADR consortium
Mar 8, 2007·The Annals of Pharmacotherapy·Diane Nykamp, Erin E Winter
Mar 23, 2011·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Payal BhallaKrishnan Ravi
Aug 23, 2018·Journal of Cardiovascular Pharmacology and Therapeutics·In Suck ChoiUNKNOWN Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH) investigators
Jul 2, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Esther Márquez-SaavedraManuel Romero-Gómez
Jun 30, 2005·Current Opinion in Allergy and Clinical Immunology·Eva Rebelo Gomes, Pascal Demoly
Apr 2, 2020·Physiological Research·J-S ShimA H Morice
Feb 9, 2011·Blood Pressure·Guido GrassiGiuseppe Mancia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.